Neurocrine Biosciences (BSP:N1BI34) Preferred Dividends : R$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Neurocrine Biosciences Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Neurocrine Biosciences's preferred dividends for the three months ended in Dec. 2023 was R$0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2023 was R$0 Mil.

Neurocrine Biosciences Preferred Dividends Historical Data

The historical data trend for Neurocrine Biosciences's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Preferred Dividends Chart

Neurocrine Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Get a 7-Day Free Trial

Neurocrine Biosciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Neurocrine Biosciences Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Neurocrine Biosciences (BSP:N1BI34) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

Neurocrine Biosciences (BSP:N1BI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (BSP:N1BI34) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

NBIX:USA NB3:Germany

Address

12780 El Camino Real, San Diego, CA, USA, 92130

Website

https://www.neurocrine.com

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (BSP:N1BI34) Headlines

No Headlines